Effects of subthalamic nucleus deep brain stimulation on neuronal spiking activity in the substantia nigra pars compacta in a rat model of Parkinson's disease.


Journal

Neuroscience letters
ISSN: 1872-7972
Titre abrégé: Neurosci Lett
Pays: Ireland
ID NLM: 7600130

Informations de publication

Date de publication:
20 11 2020
Historique:
received: 20 07 2020
revised: 30 09 2020
accepted: 14 10 2020
pubmed: 4 11 2020
medline: 1 5 2021
entrez: 3 11 2020
Statut: ppublish

Résumé

Parkinson's Disease (PD) patients undergoing subthalamic nucleus deep brain stimulation (STN-DBS) therapy can reduce levodopa equivalent daily dose (LEDD) by approximately 50 %, leading to less symptoms of dyskinesia. The underlying mechanisms contributing to this reduction remain unclear, but studies posit that STN-DBS may increase striatal dopamine levels by exciting remaining dopaminergic cells in the substantia nigra pars compacta (SNc). Yet, no direct evidence has shown how SNc neuronal activity responds during STN-DBS in PD. Here, we use a hemiparkinsonian rat model of PD and employ in vivo electrophysiology to examine the effects of STN-DBS on SNc neuronal spiking activity. We found that 43 % of SNc neurons in naïve rats reduced their spiking frequency to 29.8 ± 18.5 % of baseline (p = 0.010). In hemiparkinsonian rats, a higher number of SNc neurons (88 % of recorded cells) decreased spiking frequency to 61.6 ± 4.4 % of baseline (p = 0.030). We also noted that 43 % of SNc neurons in naïve rats increased spiking frequency from 0.2 ± 0.0 Hz at baseline to 1.8 ± 0.3 Hz during stimulation, but only 1 SNc neuron from 1 hemiparkinsonian rat increased its spiking frequency by 12 % during STN-DBS. Overall, STN-DBS decreased spike frequency in the majority of recorded SNc neurons in a rat model of PD. Less homogenous responsiveness in directionality in SNc neurons during STN-DBS was seen in naive rats. Plausibly, poly-synaptic network signaling from STN-DBS may underlie these changes in SNc spike frequencies.

Identifiants

pubmed: 33141067
pii: S0304-3940(20)30713-8
doi: 10.1016/j.neulet.2020.135443
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

135443

Informations de copyright

Copyright © 2020 Elsevier B.V. All rights reserved.

Auteurs

Siddhartha Sahai (S)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Emaan T Effendi (ET)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Emily C Mahoney (EC)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Heidi R Tucker (HR)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Benjamin J Moolick (BJ)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Gianna Mamone (G)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Saisree Mikkilineni (S)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Megan Gupta (M)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Alycia Nicholson (A)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Fu Yee Chua (FY)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Kainat Akhtar (K)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Zall Hirschstein (Z)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States.

Eric S Molho (ES)

Department of Neurology, Albany Medical Center, Albany, NY, United States.

Julie G Pilitsis (JG)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States; Department of Neurosurgery, Albany Medical Center, Albany, NY, United States.

Damian S Shin (DS)

Department of Neuroscience & Experimental Therapeutics, Albany Medical College, Albany, NY, United States; Department of Neurology, Albany Medical Center, Albany, NY, United States. Electronic address: shind@amc.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH